James B. Renacci sold Lixil Group Corp (PINK: JSGRY)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in Lixil Group Corp (JSGRY) since 2014, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of Lixil Group Corp (PINK: JSGRY) on January 24, 2014. Since that trade, JSGRY is down -21.61% against the S&P 500 up +402.02%, an outperformance of -423.63%.
Data updated
James B. Renacci's JSGRY trades vs the price
JSGRY is down -21.61% since James B. Renacci sold on January 24, 2014, versus +402.02% for the S&P 500.
Performance since this trade
All James B. Renacci JSGRY trades
James B. Renacci & JSGRY trading FAQ
Is it legal for James B. Renacci to trade Lixil Group Corp (JSGRY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Lixil Group Corp (JSGRY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell JSGRY?
James B. Renacci disclosed a sale of $15,001 - $50,000 of Lixil Group Corp (JSGRY) on January 24, 2014, according to public STOCK Act filings.
How has JSGRY performed since James B. Renacci's trade?
Since James B. Renacci sold JSGRY on January 24, 2014, the stock is down -21.61%, versus +402.02% for the S&P 500 over the same period, an outperformance of -423.63%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional JSGRY trades?
Quantellect tracks every disclosed congressional trade in Lixil Group Corp (JSGRY) on the Lixil Group Corp congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's JSGRY tradesAll congressional filings for Lixil Group CorpJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.